Comments
Loading...

Zentalis Pharma

ZNTLNASDAQ
Logo brought to you by Benzinga Data
$4.22
0.061.44%
Last update: 9:11 AM
15 minutes delayed
Consensus Rating1
Buy
Highest Price Target1
$70.00
Lowest Price Target1
$4.00
Consensus Price Target1
$20.10

Zentalis Pharma (NASDAQ:ZNTL) Stock, Analyst Ratings, Price Targets, Forecasts

Zentalis Pharmaceuticals Inc has a consensus price target of $20.1 based on the ratings of 11 analysts. The high is $70 issued by Jefferies on May 19, 2023. The low is $4 issued by Wedbush on August 12, 2024. The 3 most-recent analyst ratings were released by Oppenheimer, Wedbush, and HC Wainwright & Co. on September 16, 2024, August 12, 2024, and August 12, 2024, respectively. With an average price target of $14.67 between Oppenheimer, Wedbush, and HC Wainwright & Co., there's an implied 247.55% upside for Zentalis Pharmaceuticals Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
0
0
0
0
May
1
3
Jun
1
Aug
1
Sep
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
3.1
Hold
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Oppenheimer
Wedbush
HC Wainwright & Co.
UBS
Wells Fargo

1calculated from analyst ratings

Analyst Ratings for Zentalis Pharma

Data brought to you by Benzinga APIs

FAQ

Q

What is the target price for Zentalis Pharma (ZNTL) stock?

A

The latest price target for Zentalis Pharma (NASDAQ:ZNTL) was reported by Oppenheimer on September 16, 2024. The analyst firm set a price target for $20.00 expecting ZNTL to rise to within 12 months (a possible 373.93% upside). 17 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Zentalis Pharma (ZNTL)?

A

The latest analyst rating for Zentalis Pharma (NASDAQ:ZNTL) was provided by Oppenheimer, and Zentalis Pharma reiterated their outperform rating.

Q

When was the last upgrade for Zentalis Pharma (ZNTL)?

A

The last upgrade for Zentalis Pharmaceuticals Inc happened on August 12, 2024 when Wedbush raised their price target to $4. Wedbush previously had an underperform for Zentalis Pharmaceuticals Inc.

Q

When was the last downgrade for Zentalis Pharma (ZNTL)?

A

The last downgrade for Zentalis Pharmaceuticals Inc happened on June 20, 2024 when UBS changed their price target from $28 to $5 for Zentalis Pharmaceuticals Inc.

Q

When is the next analyst rating going to be posted or updated for Zentalis Pharma (ZNTL)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Zentalis Pharma, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Zentalis Pharma was filed on September 16, 2024 so you should expect the next rating to be made available sometime around September 16, 2025.

Q

Is the Analyst Rating Zentalis Pharma (ZNTL) correct?

A

While ratings are subjective and will change, the latest Zentalis Pharma (ZNTL) rating was a reiterated with a price target of $20.00 to $20.00. The current price Zentalis Pharma (ZNTL) is trading at is $4.22, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch